ArticleActive
Billing and Coding: B-type Natriuretic Peptide (BNP) Testing
A57083
Effective: October 1, 2022
Updated: December 31, 2025
Policy Summary
This policy provides billing and coding guidance for B-type Natriuretic Peptide (BNP) testing and requires that all claims be supported by legible medical record documentation demonstrating medical necessity. Specific covered indications, limitations, and any frequency limits are defined in the associated Local Coverage Determination (LCD); claims that do not meet the LCD documentation requirements may be denied.
Coverage Criteria Preview
Key requirements from the full policy
"Coverage and billing guidance for BNP testing are limited to the clinical indications and restrictions specified in the associated Local Coverage Determination (LCD); refer to that LCD for specific..."
Sign up to see full coverage criteria, indications, and limitations.